{"title":"人催乳素受体和多巴胺在肾上腺肿瘤细胞雌性化中的作用","authors":"N. Furuhashi, V. Fang","doi":"10.1111/J.1447-0756.1981.TB00541.X","DOIUrl":null,"url":null,"abstract":"Estrogen production by feminizing adrenal neoplastic cells (Fang-8 cells) in culture was stimulated by human prolactin (hPRL). The existence of hPRL receptor in the cells was demonstrated. The stimulatory effect of hPRL was abolished by dopamine and CB-154 (2-bromo-α-ergocriptine), since CB-154, at 60 μg/dish, inhibited cell growth and estrogen production in the absence of hPRL and since dopamine may involve different mechanisms of action. The action of CB-154 was blocked by propranolol, not by phenoxybenzamine or pimozide. Since we could not demonstrate adrenergic or dopaminergic receptor in Fang-8 cells, the interaction between CB-154 and propranolol may not be explained by a pharmacological beta-adrenergic mechanism.","PeriodicalId":8557,"journal":{"name":"Asia-Oceania journal of obstetrics and gynaecology","volume":"51 1","pages":"349-353"},"PeriodicalIF":0.0000,"publicationDate":"2010-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Human Prolactin Receptor and Dopamine Actions in Feminizing Adrenal Neoplastic Cells\",\"authors\":\"N. Furuhashi, V. Fang\",\"doi\":\"10.1111/J.1447-0756.1981.TB00541.X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Estrogen production by feminizing adrenal neoplastic cells (Fang-8 cells) in culture was stimulated by human prolactin (hPRL). The existence of hPRL receptor in the cells was demonstrated. The stimulatory effect of hPRL was abolished by dopamine and CB-154 (2-bromo-α-ergocriptine), since CB-154, at 60 μg/dish, inhibited cell growth and estrogen production in the absence of hPRL and since dopamine may involve different mechanisms of action. The action of CB-154 was blocked by propranolol, not by phenoxybenzamine or pimozide. Since we could not demonstrate adrenergic or dopaminergic receptor in Fang-8 cells, the interaction between CB-154 and propranolol may not be explained by a pharmacological beta-adrenergic mechanism.\",\"PeriodicalId\":8557,\"journal\":{\"name\":\"Asia-Oceania journal of obstetrics and gynaecology\",\"volume\":\"51 1\",\"pages\":\"349-353\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-05-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asia-Oceania journal of obstetrics and gynaecology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/J.1447-0756.1981.TB00541.X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia-Oceania journal of obstetrics and gynaecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/J.1447-0756.1981.TB00541.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Human Prolactin Receptor and Dopamine Actions in Feminizing Adrenal Neoplastic Cells
Estrogen production by feminizing adrenal neoplastic cells (Fang-8 cells) in culture was stimulated by human prolactin (hPRL). The existence of hPRL receptor in the cells was demonstrated. The stimulatory effect of hPRL was abolished by dopamine and CB-154 (2-bromo-α-ergocriptine), since CB-154, at 60 μg/dish, inhibited cell growth and estrogen production in the absence of hPRL and since dopamine may involve different mechanisms of action. The action of CB-154 was blocked by propranolol, not by phenoxybenzamine or pimozide. Since we could not demonstrate adrenergic or dopaminergic receptor in Fang-8 cells, the interaction between CB-154 and propranolol may not be explained by a pharmacological beta-adrenergic mechanism.